Navigation Links
Luminex Corporation Reports Second Quarter 2012 Results
Date:7/30/2012

ments regarding: the expansion of our installed base; distribution for our instruments; purchases of our consumable products; the development progress and market acceptance of our assay products, including NeoPlex4 and NeoPlex System and products developed and manufactured by Luminex Madison and Luminex Molecular Diagnostics; anticipated FDA clearance of our products, including Gastrointestinal Pathogen Panel, NeoPlex4 and NeoPlex System;status of integration of Luminex Madison; the acquisition of GenturaDx; the addition of Luminex to the S&P Small Cap 600 GICS; Luminex's long-term strategic plan and acquisition strategy; the ability of our investment in current initiatives and new products to deliver high performance solutions, and drive long-term value for our shareholders; and, projected 2012 revenue. The words "believe," "expect," "intend," "estimate," "anticipate," "will," "could," "should" and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.  It is important to note that the Company's actual results or performance could differ materially from those anticipated or projected in such forward-looking statements.  Factors that could cause Luminex's actual results or performance to differ materially include risks and uncertainties relating to, among others, market demand and acceptance of Luminex's products and technology, the Company's dependence on strategic partners for development, commercialization and distribution of products, concentration of the Company's revenue in a limited number of strategic partners, fluctuations in quarterly results due to a lengthy and unpredictable sales cycle and bulk purchases of consumables, Luminex's ability to scale manufacturing operations and manage operating expenses, gross margins and inventory levels, potential shortages of components, competition, the timing of regulatory approvals, the implementat
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
2. Luminex Corporation Announces Agreement to Acquire GenturaDx
3. Luminex Corporation Reports First Quarter 2012 Results
4. Unilife Corporation Announces Financial Results For Fiscal Year 2012 Fourth Quarter
5. Gentris Corporation Announces Collaboration to Study Blood Stability
6. Unilife Corporation to Announce Financial Results for Fiscal 2012 Fourth Quarter and Year End on Monday, July 30, 2012
7. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
8. Celladon Corporation Receives Patent from United States Patent and Trademark Office
9. Gentris Corporation Launches New Pharmacogenomics Services
10. BioElectronics Corporation Announces Initiative for UK and German Markets
11. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... LONDON , September 19, 2014 ... hat Pharma IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, ... abdeckt. Die interaktive PDF, verfügbar unter pharmaserialisation.com ... an dem sie jeweils in Kraft treten. ... der Serialisierung nicht länger um das "ob", sondern ...
(Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014 /PRNewswire/ ... provider of advanced cancer genome analysis and testing ... in discovering and developing highly selective kinase inhibitors ... comprehensive genomic study of malignant mixed Mullerian tumors ... female reproductive system, also known as carcinosarcoma. The ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Dec. 13, 2010 Masimo ... new clinical study demonstrating the accuracy of its latest ... week at the American Association of Respiratory Care,s ... Vegas. The largest gathering of respiratory care clinicians in ...
... BioTrends Research Group, Inc. finds that on most ... for the management of a multiple sclerosis (MS) symptom, ... product awareness, interest, satisfaction, the managed care process and ... launch, patient requests play a less impactful role in ...
Cached Medicine Technology:New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 2New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 3New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 4New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 5New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 6Acorda's Ampyra Sustains High Levels of Interest Seven Months After Launch With Favorable Future Share Projections 2
(Date:9/19/2014)... By Alan Mozes ... (HealthDay News) -- Cancer patients burdened by stress and ... for complications following their operation, a new study suggests. ... "deficit" appeared to have a nearly three times greater ... or good quality of life. "We,ve long known ...
(Date:9/19/2014)... leading anti-ageing clinic has called its HGH Therapy ... grown tremendously across USA in the last decade with new ... has far reaching benefits for ageing men and women and ... active lifestyle even beyond their middle age. , Explaining ... said, “HGH or Human Growth hormones are the building blocks ...
(Date:9/19/2014)... IRVINE, CA (PRWEB) September 19, 2014 In ... has been an active part of the project’s social ... this movement, which aims to re-define the perception of beauty ... Beauty Project began as an idea by Shelly Baer and ... showed disabled women as sexy and beautiful. Ginny Dixon, Wendy ...
(Date:9/19/2014)... two-generation approaches to reducing poverty that help children ... researchers, advocates, and foundations. By combining education and ... to jobs that offer a path out of ... children, these programs aim to improve the life ... new report from the National Center for Children ...
(Date:9/19/2014)... Hills, NY (PRWEB) September 20, 2014 As ... Prabha Krishnan DMD in Queens, NY now reminds area patients ... more than 80% of our population affected by gum disease, ... any longer.” , For over 20 years Dr. Krishnan has ... Forest Hills office location. “Most patients that come in due ...
Breaking Medicine News(10 mins):Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3
... ARBOR, Mich. Only a third of patients with ... before their initial surgery, according to a new study ... Whats more, women who did discuss reconstruction up front ... compared to those women who did not discuss reconstruction. ...
... Calif., Dec. 20 ISTA Pharmaceuticals,Inc. (Nasdaq: ... a New Drug,Application (NDA) to the U.S. Food ... Company is seeking approval for Xibrom QD,as a ... Xibrom(TM) (bromfenac ophthalmic solution), Xibrom is ...
... New research,published in the December issue of Pediatrics ... can lose weight while substituting an,ounce of peanuts ... choices. The,study, "Weight Loss in Overweight Mexican American ... and Overweight" (FLOW),Prevention Program, which is in a ...
... Mich., Dec. 20 Oakwood Healthcare,Inc. (OHI) today became ... most up-to-date and comprehensive pricing information for,hundreds of surgeries, ... This is a natural step forward as Oakwood was,the ... key,quality outcomes on its Web site more than two ...
... of Howard G. Smith,announces a September 4, 2007, ... in,the securities class action lawsuit filed on behalf ... Pharmaceuticals, Inc. ("Threshold,Pharmaceuticals" or the "Company")(Nasdaq: THLD ... (the "Class Period"), including purchasers in Threshold,s,February 4, ...
... humanitarian organization distorts ... history and law, WASHINGTON, Aug. ... Johnson & Johnson (J&J), the American,Red Cross today released a detailed rebuttal, ... emblem. "The mission of the Red Cross is to prevent, prepare ...
Cached Medicine News:Health News:Most breast cancer surgeons don't talk to patients about reconstruction options, U-M study finds 2Health News:ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily) 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 3Health News:Oakwood is First Healthcare System in Southeast Michigan to Post Pricing Information on Web Site 2Health News:Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc. 2Health News:American Red Cross Defends Use of Emblem and Mission 2Health News:American Red Cross Defends Use of Emblem and Mission 3Health News:American Red Cross Defends Use of Emblem and Mission 4Health News:American Red Cross Defends Use of Emblem and Mission 5Health News:American Red Cross Defends Use of Emblem and Mission 6
4 mm disposable bevel blade. Malleable shafts. Flat spot on handle designed to guide knife in perforation....
Consist of 6 disposable bevel blades (N0522) and chuck handle (0521). Malleable shafts. Designated most popular model or size....
Straight 9 mm downcutting Royce blade. Can be placed in closed handle for protection. Handle length folded 109 mm, 4.3 inches. Blade can be set automatically and rigidly at any point from straight to...
2 mm diameter blade. Angled 60 degrees. Sharp. Round handle....
Medicine Products: